Market Research Logo

Global Statin Market 2019-2023

Global Statin Market 2019-2023

About this market

The increasing statin use will help the market grow at a steady rate. In the US and the UK, people aged 40 and above are recommended to monitor their cholesterol level. Statins are considered an evidence-based treatment for high risk patients with elevated cardiovascular disorder. Technavio’s analysts have predicted that the statin market will register a CAGR of over 2% by 2023.

Market Overview

Rising prevalence of hypercholesterolemia

The rising prevalence of hypercholesterolemia is fueling the demand for generic cholesterol medications. Cardiovascular disease is one of the primary causes of mortality in Western countries.

Fierce generic competition

Patient expiration is a major challenge for companies developing branded drugs as it provides an opportunity for the development of generic drugs.

For the detailed list of factors that will drive and challenge the growth of the statin market during the 2019-2023, view our report.

Competitive Landscape

The market appears to be fragmented and with the presence of several companies including AstraZeneca and Merck the competitive environment is quite intense. Factors such as the increasing statin use and the rising prevalence of hypercholesterolemia, will provide considerable growth opportunities to statin manufactures. AstraZeneca, Merck, Pfizer, and Novartis are some of the major companies covered in this report.

‘With the presence of a considerable number of companies, this market appears to be fragmented. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies. Many established statin manufacturers are vying for their share of the global statin market, and the new players must differentiate themselves to gain vital traction over their competitors.’


PRESS RELEASE

Technavio Announces the Publication of its Research Report – Global Statin Market 2019-2023

Technavio recognizes the following companies as the key players in the global statin market: AstraZeneca, Merck, Pfizer, and Novartis.

Commenting on the report, an analyst from Technavio’s team said: “The latest trend gaining momentum in the market is increasing statin use.”

According to the report, one of the major drivers for this market is the rising prevalence of hypercholesterolemia.

Further, the report states that one of the major factors hindering the growth of this market is fierce generic competition.

Companies Mentioned

AstraZeneca

Merck

Novartis

Pfizer

  • Executive summary
  • Scope of the report
    • Preface
    • Currency conversion rates for US$
  • Market landscape
    • Market ecosystem
      • Table Global CVD treatment market
      • Table Segments of global CVD treatment market
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Market segments
    • Pipeline
      • Table List of statins evaluated in late-stage clinical trials
  • Market sizing
    • Market definition
      • Table Market definition - Inclusions and exclusions checklist
    • Market sizing 2018
      • Table Market size 2018
    • Market size and forecast 2018-2023
      • Table Global market: Size and forecast 2018-2023 ($ millions)
      • Table Global market: Year-over-year growth 2019-2023 (%)
  • Five forces analysis
    • Table Five forces analysis 2018
    • Table Five forces analysis 2023
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2018
  • Market segmentation by type
    • Table Type - Market share 2018-2023 (%)
    • Comparison by type
      • Table Comparison by type
    • Synthetic statins - Market size and forecast 2018-2023
      • Table List of some synthetic statins
      • Table Synthetic statins - Market size and forecast 2018-2023 ($ millions)
      • Table Synthetic statins - Year-over-year growth 2019-2023 (%)
    • Natural statins - Market size and forecast 2018-2023
      • Table Examples of natural statins
      • Table Natural statins - Market size and forecast 2018-2023 ($ millions)
      • Table Natural statins - Year-over-year growth 2019-2023 (%)
    • Market opportunity by type
      • Table Market opportunity by type
  • Customer landscape
    • Table Customer landscape
  • Market segmentation by application
    • Dyslipidemia
    • Others
  • Geographic landscape
    • Geographic segmentation
      • Table Market share by geography 2018-2023 (%)
    • Geographic comparison
      • Table Geographic comparison
    • Americas - Market size and forecast 2018-2023
      • Table Americas - Market size and forecast 2018-2023 ($ millions)
      • Table Americas - Year-over-year growth 2019-2023 (%)
    • EMEA - Market size and forecast 2018-2023
      • Table EMEA - Market size and forecast 2018-2023 ($ millions)
      • Table EMEA - Year-over-year growth 2019-2023 (%)
    • APAC - Market size and forecast 2018-2023
      • Table APAC - Market size and forecast 2018-2023 ($ millions)
      • Table APAC - Year-over-year growth 2019-2023 (%)
    • Key leading countries
      • Table Key leading countries
    • Market opportunity
      • Table Market opportunity
  • Decision framework
  • Drivers and challenges
    • Market drivers
    • Market challenges
      • Table Status of generic availability in US
      • Table Impact of generics on sales of branded products
      • Table Potential statin-drug interactions
      • Table Commonly occurring side effects of some statins
      • Table Impact of drivers and challenges
  • Market trends
    • Table Mobile apps for cholesterol management
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
  • Vendor analysis
    • Vendors covered
      • Table Vendors covered
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • AstraZeneca
      • Table AstraZeneca - Vendor overview
      • Table AstraZeneca - Business segments
      • Table AstraZeneca - Organizational developments
      • Table AstraZeneca - Geographic focus
      • Table AstraZeneca - Key offerings
    • Merck
      • Table Merck - Vendor overview
      • Table Merck - Business segments
      • Table Merck - Organizational developments
      • Table Merck - Geographic focus
      • Table Merck - Segment focus
      • Table Merck - Key offerings
    • Novartis
      • Table Novartis - Vendor overview
      • Table Novartis - Business segments
      • Table Novartis - Organizational developments
      • Table Novartis - Geographic focus
      • Table Novartis - Segment focus
      • Table Novartis - Key offerings
    • Pfizer
      • Table Pfizer - Vendor overview
      • Table Pfizer - Business segments
      • Table Pfizer - Organizational developments
      • Table Pfizer - Geographic focus
      • Table Pfizer - Segment focus
      • Table Pfizer - Key offerings
  • Appendix
    • Research methodology
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report